These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15205200)

  • 1. Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.
    Di Cosimo S; Alimonti A; Ferretti G; Sperduti I; Carlini P; Papaldo P; Fabi A; Gelibter A; Ciccarese M; Giannarelli D; Mandalà M; Milella M; Ruggeri EM; Cognetti F
    Ann Oncol; 2004 Jul; 15(7):1065-71. PubMed ID: 15205200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study.
    Sukumvanich P; Case LD; Van Zee K; Singletary SE; Paskett ED; Petrek JA; Naftalis E; Naughton MJ
    Cancer; 2010 Jul; 116(13):3102-11. PubMed ID: 20564648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].
    Li HP; Ma LW; Zhang SL; Jia TZ; Deng HJ; Zhang ZH; Liang L; Wang MP; Xiao Y; Cao BS; Chen S; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):848-51. PubMed ID: 17416008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levels.
    Meng K; Tian W; Zhou M; Chen H; Deng Y
    World J Surg Oncol; 2013 May; 11():101. PubMed ID: 23688389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens.
    Pérez-Fidalgo JA; Roselló S; García-Garré E; Jordá E; Martín-Martorell P; Bermejo B; Chirivella I; Guzman C; Lluch A
    Breast Cancer Res Treat; 2010 Feb; 120(1):245-51. PubMed ID: 19575291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced amenorrhea and the resumption of menstruation in premenopausal women with hormone receptor-positive early breast cancer.
    Koga C; Akiyoshi S; Ishida M; Nakamura Y; Ohno S; Tokunaga E
    Breast Cancer; 2017 Sep; 24(5):714-719. PubMed ID: 28243992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
    Iwamoto T; Hara F; Uemura Y; Mukai H; Watanabe T; Ohashi Y
    Breast Cancer Res Treat; 2020 Jul; 182(2):325-332. PubMed ID: 32462261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
    Tham YL; Sexton K; Weiss H; Elledge R; Friedman LC; Kramer R
    Am J Clin Oncol; 2007 Apr; 30(2):126-32. PubMed ID: 17414460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
    Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients.
    Vanhuyse M; Fournier C; Bonneterre J
    Ann Oncol; 2005 Aug; 16(8):1283-8. PubMed ID: 15870085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of chemotherapy-induced amenorrhea on premenopausal breast cancer: a meta-analysis of the literature.
    Zhou Q; Yin W; Du Y; Shen Z; Lu J
    Menopause; 2015 Oct; 22(10):1091-7. PubMed ID: 25783467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea.
    Najafi S; Djavid GE; Mehrdad N; Rajaii E; Alavi N; Olfatbakhsh A; Najafi M; Bahrami A; Heidari K
    Menopause; 2011 Feb; 18(2):208-12. PubMed ID: 21037487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy-Induced Amenorrhea and Menopause Symptoms in Women With Breast Cancer].
    Li CY; Chen ML
    Hu Li Za Zhi; 2016 Oct; 63(5):19-26. PubMed ID: 27699736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study.
    Reimer T; Kempert S; Gerber B; Thiesen HJ; Hartmann S; Koczan D
    BMC Cancer; 2016 May; 16():337. PubMed ID: 27234217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis.
    Zhao J; Liu J; Chen K; Li S; Wang Y; Yang Y; Deng H; Jia W; Rao N; Liu Q; Su F
    Breast Cancer Res Treat; 2014 May; 145(1):113-28. PubMed ID: 24671358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.
    Fornier MN; Modi S; Panageas KS; Norton L; Hudis C
    Cancer; 2005 Oct; 104(8):1575-9. PubMed ID: 16134178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
    Ruddy KJ; Guo H; Barry W; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis MJ; Shapira I; Wolff AC; Carey LA; Overmoyer BA; Hudis C; Krop IE; Burstein HJ; Winer EP; Partridge AH; Tolaney SM
    Breast Cancer Res Treat; 2015 Jun; 151(3):589-96. PubMed ID: 25981899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.
    Zhou W; Ding Q; Liang X; He Z; Zha X; Liu X; Wang S
    PLoS One; 2012; 7(5):e37249. PubMed ID: 22615953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients.
    Jeon SJ; Lee JI; Jeon MJ; Lee M
    Medicine (Baltimore); 2016 Apr; 95(14):e3301. PubMed ID: 27057900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women.
    Milella M; Nisticò C; Ferraresi V; Vaccaro A; Fabi A; D'Ottavio AM; Botti C; Giannarelli D; Lopez M; Cortesi E; Foggi CM; Antimi M; Terzoli E; Cognetti F; Papaldo P
    Breast Cancer Res Treat; 1999 Jun; 55(3):259-66. PubMed ID: 10517170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.